Source: American Society for Radiation Oncology (ASTRO) From: news-medical.net Three leading national cancer organizations today issued a joint clinical practice guideline update for physicians treating women with breast cancer who have undergone a mastectomy. The update provides additional considerations for physicians to determine which patients might benefit from postmastectomy radiotherapy (PMRT). “We still don’t have a single, validated formula that …
Doctor-Patient Dialogue After a Cancer Diagnosis
View PostHow Do You Know If a Cancer Treatment Is Best for You
View PostStudy finds potential new biomarker for cancer patient prognosis
Source: DOE/Lawrence Berkeley National Laboratory From: eurekalert.org To treat or not to treat? That is the question researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing. Berkeley Lab researchers identified 14 genes regulating …
New surgical option for breast cancer comes to the US
From: medicalxpress.com Breast cancer patients in the U.S. will have a new surgical option that eliminates exposure to radioactive materials and offers a less invasive, more flexible alternative for cancer detection. Receiving FDA approval in April and a distribution deal this month, the new device will be used to locate early stage tumors that cannot yet be felt. Co-invented by …
Gene test can reduce chemo use among breast-cancer patients, study says
By: Laurie McGinley From: washingtonpost.com Doctors have long known that many early-stage breast cancer patients who undergo chemotherapy don’t actually need it to prevent recurrence of the disease after surgery. But they haven’t known exactly which patients might safely skip the toxic treatment. A European study published Wednesday in the New England Journal of Medicine sheds new light on the …
New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials
Source: University of Central Florida From: news-medical.net A University of Central Florida cancer researcher has discovered a way to kill spreading breast cancer cells and her new technology has generated a licensing agreement that will accelerate the therapy’s path to clinical trials. Metastatic cancer cells that spread from the original tumor to the brain, lungs and bones are the leading …
Hormone Therapy After Breast Cancer Surgery
Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy
Source: University of Colorado Anschutz Medical Campus From: news-medical.net Previous studies at the University of Colorado Cancer Center show that the experimental drug AMPI-109 potently kills triple-negative breast cancer cells. But even the most compelling evidence of cell death in a dish isn’t enough to push a drug into human clinical trials, even for triple-negative breast cancer, which has a …
Breast Cancer Risk Increases Threefold On Combined HRT Usage, Study Finds
By: Mary Pascaline From: ibtimes.com Women who use combined hormone replacement therapy (HRT) can increase their risk of breast cancer by about three times, researchers found. They added that previous studies had dangerously underestimated this risk. HRT is used to treat menopause symptoms like hot flushes migraines, disrupted sleep, mood changes and depression. Estimates say that at least one in …